Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites.
D000818:Animals; D002448:Cell Adhesion / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006098:Granulocytes / Q000187:drug effects*; D006801:Humans; D007249:Inflammation / Q000097:blood; D007275:Injections, Intravenous; D008012:Lidocaine / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D008297:Male; D010538:Peritonitis / Q000097:blood; D011817:Rabbits; D012867:Skin / Q000473:pathology; D013211:Staphylococcus aureus
D008012:Lidocaine